187 related articles for article (PubMed ID: 25775949)
1. Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.
Zhuang CL; Fu X; Liu L; Liu YC; Huang WR; Cai ZM
Tumour Biol; 2015 Jul; 36(7):5157-63. PubMed ID: 25775949
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer.
Liu L; Liu Y; Zhang T; Wu H; Lin M; Wang C; Zhan Y; Zhou Q; Qiao B; Sun X; Zhang Q; Guo X; Zhao G; Zhang W; Huang W
J Exp Clin Cancer Res; 2016 Jan; 35():3. PubMed ID: 26743236
[TBL] [Abstract][Full Text] [Related]
3. Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
Liu Y; Han Y; Zhang H; Nie L; Jiang Z; Fa P; Gui Y; Cai Z
PLoS One; 2012; 7(12):e52280. PubMed ID: 23284967
[TBL] [Abstract][Full Text] [Related]
4. Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
Fu WJ; Hong BF; Huang JJ; Xu B; Gao JP; Wang XX; Huang CF
BJU Int; 2005 Oct; 96(6):890-4. PubMed ID: 16153224
[TBL] [Abstract][Full Text] [Related]
5. Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells.
Xie H; Zhan H; Gao Q; Li J; Zhou Q; Chen Z; Liu Y; Ding M; Xiao H; Liu Y; Huang W; Cai Z
Cancer Lett; 2018 May; 422():94-106. PubMed ID: 29501702
[TBL] [Abstract][Full Text] [Related]
6. An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells.
Huang X; Zhuang C; Zhuang C; Xiong T; Li Y; Gui Y
Mol Biosyst; 2017 Aug; 13(9):1713-1721. PubMed ID: 28702647
[TBL] [Abstract][Full Text] [Related]
7. Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.
Zhuang C; Huang X; Zhuang C; Luo X; Zhang X; Cai Z; Gui Y
J Exp Clin Cancer Res; 2017 Oct; 36(1):151. PubMed ID: 29084575
[TBL] [Abstract][Full Text] [Related]
8. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
[TBL] [Abstract][Full Text] [Related]
9. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
10. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
11. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
Chen L; Lü MH; Zhang D; Hao NB; Fan YH; Wu YY; Wang SM; Xie R; Fang DC; Zhang H; Hu CJ; Yang SM
Cell Death Dis; 2014 Jan; 5(1):e1034. PubMed ID: 24481448
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
Fei X; Qi M; Wu B; Song Y; Wang Y; Li T
FEBS Lett; 2012 Feb; 586(4):392-7. PubMed ID: 22265971
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
Lin J; Liu Y; Zhan Y; Zhuang C; Liu L; Fu X; Xu W; Li J; Chen M; Cai Z; Huang W
Tumour Biol; 2016 Mar; 37(3):3115-21. PubMed ID: 26427661
[TBL] [Abstract][Full Text] [Related]
14. TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Agarwal N; Rinaldetti S; Cheikh BB; Zhou Q; Hass EP; Jones RT; Joshi M; LaBarbera DV; Knott SRV; Cech TR; Theodorescu D
Proc Natl Acad Sci U S A; 2021 Sep; 118(38):. PubMed ID: 34518220
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
Zhan Y; Liu Y; Lin J; Fu X; Zhuang C; Liu L; Xu W; Li J; Chen M; Zhao G; Huang W; Cai Z
Sci Rep; 2015 Nov; 5():16177. PubMed ID: 26541358
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
Gao XD; Chen YR
Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
[TBL] [Abstract][Full Text] [Related]
17. The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.
Zhang X; Liu X; Jing Z; Bi J; Li Z; Liu X; Li J; Li Z; Zhang Z; Kong C
Cancer Gene Ther; 2020 Apr; 27(3-4):189-202. PubMed ID: 30723269
[TBL] [Abstract][Full Text] [Related]
18. Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
Fu X; Liu Y; Zhuang C; Liu L; Cai Z; Huang W
Mol Biosyst; 2015 May; 11(5):1285-9. PubMed ID: 25800227
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
20. miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT.
Zhang D; Xiao YF; Zhang JW; Xie R; Hu CJ; Tang B; Wang SM; Wu YY; Hao NB; Yang SM
Cancer Lett; 2015 May; 360(2):151-9. PubMed ID: 25662441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
